The new era of cancer immunotherapy: targeting myeloid-derived suppressor cells to overcome immune evasion

P De Cicco, G Ercolano, A Ianaro - Frontiers in immunology, 2020 - frontiersin.org
Suppression of antitumor immune responses is one of the main mechanisms by which tumor
cells escape from destruction by the immune system. Myeloid-derived suppressor cells …

Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer

K Li, H Shi, B Zhang, X Ou, Q Ma, Y Chen… - Signal transduction and …, 2021 - nature.com
Myeloid-derived suppressor cells (MDSCs) are a heterogenic population of immature
myeloid cells with immunosuppressive effects, which undergo massive expansion during …

Myeloid-derived suppressor cells in cancer immunotherapy-clinical perspectives

K Mortezaee - Life sciences, 2021 - Elsevier
Myeloid-derived suppressor cells (MDSCs) are heterogeneous and poorly mature cells of
innate immunity that their population is increased substantially in cancer patients. MDSCs …

Myeloid-derived suppressor cells

DI Gabrilovich - Cancer immunology research, 2017 - AACR
Myeloid cells developed evolutionarily as a major mechanism to protect the host. They
evolved as a critical barrier against infections and are important contributors to tissue …

Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond

Y Zhao, J Du, X Shen - Frontiers in Immunology, 2023 - frontiersin.org
Myeloid-derived suppressor cells (MDSCs) are one of the major negative regulators in tumor
microenvironment (TME) due to their potent immunosuppressive capacity. MDSCs are the …

Myeloid derived suppressor cells—an overview of combat strategies to increase immunotherapy efficacy

O Draghiciu, J Lubbers, HW Nijman, T Daemen - Oncoimmunology, 2015 - Taylor & Francis
Myeloid-derived suppressor cells (MDSCs) contribute to tumor-mediated immune escape
and negatively correlate with overall survival of cancer patients. Nowadays, a variety of …

Immunosuppressive effects of myeloid-derived suppressor cells in cancer and immunotherapy

M Krishnamoorthy, L Gerhardt, S Maleki Vareki - Cells, 2021 - mdpi.com
The primary function of myeloid cells is to protect the host from infections. However, during
cancer progression or states of chronic inflammation, these cells develop into myeloid …

Myeloid-derived suppressor cells in tumors: from mechanisms to antigen specificity and microenvironmental regulation

Y Yang, C Li, T Liu, X Dai, AV Bazhin - Frontiers in immunology, 2020 - frontiersin.org
Among the various immunological and non-immunological tumor-promoting activities of
myeloid-derived suppressor cells (MDSCs), their immunosuppressive capacity remains a …

Myeloid-derived suppressor cells in cancer and cancer therapy

SA Lasser, FG Ozbay Kurt, I Arkhypov, J Utikal… - Nature Reviews …, 2024 - nature.com
Anticancer agents continue to dominate the list of newly approved drugs, approximately half
of which are immunotherapies. This trend illustrates the considerable promise of cancer …

The role of myeloid-derived suppressor cells (MDSC) in cancer progression

V Umansky, C Blattner, C Gebhardt, J Utikal - Vaccines, 2016 - mdpi.com
The immunosuppressive tumor microenvironment represents not only one of the key factors
stimulating tumor progression but also a strong obstacle for efficient tumor immunotherapy …